Upregulated miR‑665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion
Authors:
Open Access
- 11 March 2020
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 19 (5) , 3578-3586
Abstract
Non-small cell lung cancer (NSCLC) is one of the leading causes of global cancer-associated mortality. Aberrant microRNAs (miRs) have been reported to be involved in the pathogenesis of various cancer types. The present study aimed to investigate the expression profile and prognostic value of miR‑665 in patients with NSCLC, and to analyze its functional role in tumor progression using NSCLC cells. Reverse transcription‑quantitative PCR was used to estimate the expression levels of miR‑665. Kaplan‑Meier survival curves and Cox regression analysis were performed to evaluate the prognostic value of miR‑665. The effects of miR‑665 on NSCLC cell proliferation, migration and invasion were examined by cell transfection, and the target gene of miR‑665 was explored. miR‑665 expression was elevated in the tissue and cell samples of NSCLC. This increased miR‑665 expression was associated with lymph node metastasis and TNM stage. An independent association between miR‑665 and overall survival was identified in patients with NSCLC. When regulating the expression levels of miR‑665 in vitro, NSCLC cell proliferation, migration and invasion were enhanced by overexpression of miR‑665, but were inhibited by knockdown of miR‑665. The luciferase activity results indicated that the protein tyrosine phosphatase receptor type B (PTPRB) was a direct target of miR‑665 in NSCLC cells. The present study provided evidence for the clinical significance of a decreased expression of miR‑665 in the prognosis of NSCLC. Upregulation of miR‑665 contributed to tumor cell proliferation, migration and invasion by targeting PTPRB, suggesting the potential of miR‑665 as a candidate therapeutic target for NSCLC treatment.Keywords
This publication has 36 references indexed in Scilit:
- Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapyInternational Journal of Nanomedicine, 2018
- Mutations of key driver genes in colorectal cancer progression and metastasisCancer and Metastasis Reviews, 2018
- MicroRNAs associated with therapy of non-small cell lung cancerInternational Journal of Biological Sciences, 2018
- Staging of Non–Small-Cell Lung CancerPET Clinics, 2018
- Progress and prospects of early detection in lung cancerOpen Biology, 2017
- SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancerScientific Reports, 2017
- In vivo visualization of endogenous miR-21 using hyaluronic acid-coated graphene oxide for targeted cancer therapyBiomaterials, 2017
- MicroRNA-targeted therapeutics for lung cancer treatmentExpert Opinion on Drug Discovery, 2016
- Lung Cancer Staging and Prognosis2016
- Lung Cancer Statistics2015